5 results
Cardiovascular and renal effects comparison between SGLT-2 inhibitors
 - Canagliflozin (Invokana)
 - Dapagliflozin (Farxiga)
 - Empagliflozin
Cardiovascular and ... - Canagliflozin ... (Invokana) - Dapagliflozin ... (Farxiga) - Empagliflozin ... (Steglatro) #diabetes
SGLT2 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
SGLT2 Inhibitors ... gliflozin): • Empagliflozin ... the three • Dapagliflozin ... • Euglycemic diabetic ... #Summary #DM2 #diabetes
SGLT2 inhibitors, also called gliflozins, are a class of medications that alter essential physiology of the
that modulate sodium ... treatment of type II diabetes ... provide significant cardiovascular ... (Invokana®), dapagliflozin ... , #dapagliflozin
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

CONCLUSIONS:
Among patients with heart failure and a
Dapagliflozin in ... or death from cardiovascular ... those who received dapagliflozin ... or absence of diabetes ... Kosalan Akilan #Dapagliflozin
#diabetes #T2DM #antidiabeticagents #oraldiabeticagents

FIGURE 9.1 Glucose-lowering medication in type 2 diabetes: overall approach. For appropriate context,
#diabetes #T2DM ... the Effects of Canagliflozin ... on Renal and Cardiovascular ... dipeptidyl peptidase 4 inhibitor ... SGLT2i, SGLT2 inhibitor